DAO p.Arg199Gln
c.596G>A · rs200850756 · VCV3045347
Computational evidence
| Protein change | ||
| AlphaMissense | 0.3787 | ambiguous |
|---|---|---|
| REVEL | 0.679 | pathogenic-leaning |
| SaProt | LLR -15.56 | damaging |
| ⇒ REVEL and SaProt both call this damaging; AlphaMissense makes no call. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 12 | GERP 1.7, phastCons 1 |
| Regional constraint | o/e 0.99 | unconstrained · MANE · 16 kb · p 0.87 · regional, not allelic |
| Overall | ||
| CADD | 34.0 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| South Asiangrpmax | 0.214% | 467 |
| Ashkenazi Jewishnot grpmax-eligible | 0.196% | 510 |
| Remaining individualsnot grpmax-eligible | 0.0737% | 1,358 |
| European (non-Finnish) | 0.0198% | 5,061 |
| African / African-American | 0.0107% | 9,375 |
| Admixed American | 0.00834% | 11,991 |
| Finnishnot grpmax-eligible | 0.00156% | 63,964 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- DAO
- Protein
- p.Arg199Gln
- Coding
- c.596G>A
- MANE Select
- NM_001917
- dbSNP
- rs200850756
- Type
- single nucleotide variant
- Location
- chr12:108894351 (GRCh38)
- Gene constraint
- LOEUF 1.222 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 96.26 · 22 PDB
- Residue 199
- a UniProt-annotated variant site (found in a patient with als; impairs fad binding; over 200-fold decreased affinity for d-serine; 1800-fold decreased affinity for d-alanine); a UniProt-annotated variant site (found in a patient with als; decreased function in d-serine catabolic process; 3- to 4-fold decrease in vmax with d-serine, d-alanine and d-proline as substrates; impairs fad binding; decreased affinity for d-serine, d-alanine and d-proline; leads to tetramerization of the holoenzyme; leads to the formation of ubiquitinated protein aggregates; promotes induction of apoptosis; causes cell death in motor neurons in a manner at least partially dependent on the n-methyl-d-aspartic acid receptor); a β-strand
Disease context
Similar variants
- DAO p.Arg199Trp Likely benign ⚠ same residue
- DAO p.Arg290Gln Uncertain significance ★ ⚠ same condition
- DAO p.Arg297His Uncertain significance ★ ⚠ same condition
- DAO p.Arg2Ser Uncertain significance ★ ⚠ same condition
- DAO p.Arg38His Uncertain significance ★ ⚠ same condition
- DAO p.Gly131Cys Uncertain significance ★ ⚠ same condition
- DAO p.Pro103= Uncertain significance ★ same condition
- DAO p.Thr235Ile Uncertain significance ★ ⚠ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/dao-p-arg199gln (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown